Impax, Teva Put Generic-Wellbutrin MDL To Bed
A Pennsylvania federal judge on Wednesday granted preliminary approval for the settlement of multidistrict consumer fraud litigation claiming Impax Laboratories Inc.'s generic version of the antidepressant Wellbutrin XL was deceptively labeled...To view the full article, register now.
Already a subscriber? Click here to view full article